Selling second best: how infant formula marketing works by Hastings, Gerard et al.
1 RESEARCH Open Access
2 SellingQ1 second best: how infant formula
3 marketing works
4Q2 Gerard Hastings1,2*, Kathryn Angus1, Douglas Eadie1 and Kate Hunt156
7 Abstract
8 Background: Despite the clear policy intent to contain it, the marketing of formula milk remains widespread,
9 powerful and successful. This paper examines how it works.
10 Methods: The study comprised a mix of secondary analysis of business databases and qualitative interviews with
11 marketing practitioners, some of whom had previously worked in formula marketing.
12 Results: The World Health Assembly Code aims to shield parents from unfair commercial pressures by stopping the
13 inappropriate promotion of infant formula. In reality marketing remains widespread because some countries (e.g.
14 the USA) have not adopted the Code, and elsewhere industry has developed follow-on and specialist milks with
15 which they promote formula by proxy. The World Health Assembly has tried to close these loopholes by extending
16 its Code to these products; but the marketing continues. The campaigns use emotional appeals to reach out to and
17 build relationships with parents and especially mothers. Evocative brands give these approaches a human face. The
18 advent of social media has made it easier to pose as the friend and supporter of parents; it is also providing
19 companies with a rich stream of personal data with which they hone and target their campaigns.
20 The formula industry is dominated by a small number of extremely powerful multinational corporations with the
21 resources to buy the best global marketing expertise. Like all corporations they are governed by the fiduciary
22 imperative which puts the pursuit of profits ahead of all other concerns. This mix of fiscal power, sophisticated
23 marketing, and single-mindedness is causing great harm to public health.
24 Conclusions: Formula marketing is widespread and using powerful emotional techniques to sell parents a product
25 that is vastly inferior to breast milk. There is an urgent need to update and strengthen regulation.
26 Keywords: Commercial determinants of ill-health, Infant formula, Breast milk substitutes, Marketing, Multinational
27
corporations, Corporate power
28 BackgroundQ5
29 The commercial determinants of ill-health are now well
30 recognised. In particular, many of the products we con-
31 sume – tobacco, processed food, alcohol, petrochemicals,
32 leaded paint, guns – are known to have caused such harm,
33 even when used as intended, that a new descriptor, the ‘in-
34 dustrial epidemic’ [1], has been coined. Whilst free choice
35 and consumer sovereignty are much lauded, in reality this
36destructive consumption behaviour is not altogether vol-
37untary; we are energetically encouraged to smoke, drive
38cars and arm ourselves by those who gain from our self-
39harm - the companies that make and sell these products.
40In recent years these industries have grown in size, led by
41multinational corporations with powerful lobbying and
42corporate affairs functions with which to engage policy
43makers. So, soda makers can influence the Centers for
44Disease Control and Prevention [2], oil companies under-
45mine climate science [3] and the paint industry exonerate
46lead [4], and in the process regulation is avoided, delayed
47or contained.
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48 This ensures an environment where marketing – the
49 persuasive tool of choice for consumers – can be used
50 with maximum efficiency. Its capacity to encourage con-
51 sumption has been established in multiple studies for to-
52 bacco, alcohol and processed food [5–7]. The methods
53 used by marketers have also been examined, and the role
54 of emotional appeals, branding and careful targeting noted
55 [5]. The advent of digital technologies has raised further
56 concerns about the insidious power of social media mar-
57 keting, and the bespoke, deep messaging it facilitates.
58 Facebook gets over 98% of its income from advertising [8],
59 and the Cambridge Analytica revelations show how perva-
60 sive and profound digital influence has become [9].
61 This paper concerns an industrial epidemic that has
62 been going on for four decades in the infant feeding do-
63 main: the breast milk substitutes (BMS) industry. A recent
64 analysis shows that if all babies were breastfed as the
65 World Health Organization (WHO) recommends, over
66 800,000 infant deaths would be avoided each year [10].
67 BMS also harm the intellectual development of the baby
68 to such an extent that it is possible to detect the impact
69 on GDP of a predominantly bottle-fed population [11]. In
70 addition, there is an increased risk of breast cancer for the
71 mother [10], and significant ecological harm: packaging,
72 supply chains and bottle-feeding apparatus all have a car-
73 bon footprint and introduce durable plastics into the en-
74 vironment [11]. The competition, breast milk, has none of
75 these drawbacks, and comes with natural antibodies that
76 turn it into “a personalised medicine for infants” [10];
77 manufactured products cannot begin to replicate these
78 benefits. Breast milk is also much cheaper. Bottle feeding
79 a baby for six months in the UK today costs £175 (approx.
80 US$210) for the cheapest own-label products, and more
81 than double that for a premium brand [12], and these fig-
82 ures do not include any equipment, such as bottles, teats
83 and sterilisers. Comparable data from the USA suggest
84 that it could cost between US$451 and $810 to buy BMS
85 product to feed a baby for six months [13]. There are
86 some advantages to bottle-feeding: for some women,
87 breastfeeding can be difficult to instigate and maintain so
88 formula is a necessary alternative; conflicts can arise (for
89 mothers or observers) between the feeding and sexual
90 functions of the breast; and unsupportive public and work
91 places make breastfeeding difficult. The fact that breast-
92 feeding is not readily accommodated by the world of work
93 worldwide makes it particularly challenging for women to
94 breastfeed in the absence of or beyond any period of ma-
95 ternity leave. This is a marked problem in low-income
96 countries where welfare systems are less well-developed.
97 However, in most cases, when taken in the context of
98 threats to the baby’s life and future prospects, or the risk
99 of cancer, these benefits become much less persuasive.
100 Selling a product which falls so far behind the compe-
101 tition seems challenging, but the evidence shows it can
102and is being done with remarkable success. Marketing
103has, as with other health harming products, been proven
104to encourage formula consumption [14] and sales are in-
105creasing 8% year-on-year; the global market for BMS
106products was forecast to reach US$70.7 billion by 2019
107[11]. Across the world, in high- and low-income coun-
108tries alike, only 40% of mothers now follow WHO
109breastfeeding guidelines [15].
110Concerns about the marketing of infant formula are
111not new. Forty years ago, the World Health Assembly
112(WHA; the decision-making body of the world’s Mem-
113ber States) developed its International Code of Market-
114ing of Breast-milk Substitutes [16] which required
115companies to acknowledge the superiority of breast milk,
116and outlawed any advertising or promotion of BMS to
117the general public. In reality, marketing remains wide-
118spread because some countries (e.g. the USA) have not
119adopted the Code and elsewhere industry has developed
120follow-on and specialist milks which they use to pro-
121mote infant formula by proxy – that is, they are branded
122in exactly the same way and the boundaries between in-
123fant formula and follow-on and other products are
124blurred. The WHA has moved to close these loopholes
125by clarifying that the Code also applies to these products
126[17]; but the marketing continues. The advent and pro-
127liferation of digital media has further undermined the
128Code.
129This study was designed to understand how BMS for-
130mula marketers have succeeded, despite the known in-
131feriority of their product in comparison with breast milk
132and the exigencies of the Code. Their methods have pre-
133viously been audited and described [16, 18–22]; we
134aimed to analyse and explain them.
135Methods
136We used a mixed methods approach involving two
137linked data collection exercises: a review of publicly
138available data on the global marketing of breast milk
139substitutes, followed by qualitative interviews with mar-
140keting practitioners with experience of breast milk sub-
141stitutes and food marketing.
142Marketing and business literature review
143The marketing review was designed to identify docu-
144ments and data to describe the scale of the global breast
145milk substitutes market, including current forecasting of
146future directions and priorities of marketing strategies;
147to identify marketing and brand strategies; and to inform
148the qualitative interviews.
149A range of search techniques, including snowballing, was
150used to identify relevant material. Subscription business,
151academic and practitioner databases were searched in
152April–May 2019: Business Source Complete, IBISWorld,
153Marketline Industry Profiles, Nexis, SAGE Business Cases,
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154 Statista and WARC (World Advertising Research Center).
155 Example search terms included: babies formula, baby for-
156 mula, baby nutrition, bottle feeding, breast milk, breastmilk,
157 follow-on milk, infant formula, milk powder, milkpowder,
158 mother’s milk substitute, mother’s milk, powdered formula,
159 powdered milk, toddler formula, toddler milk. A generic
160 search engine and the reference lists and bibliographies of
161 relevant reports were used to identify further market re-
162 search intelligence reports and global marketing materials.
163 Websites of the two BMS producers with the largest global
164 market share [18] were searched for reports and informa-
165 tion for shareholders, as well as marketing examples for
166 their brands.
167 The analysis of documents and secondary data was not
168 intended to be comprehensive; rather we aimed to update
169 accessible data on the scale of the BMS market and pro-
170 vide illustrative business and marketing strategies. The
171 documents and data often referred to the much broader
172 categories of baby and infant food and nutrition, thus
173 market and marketing data for the BMS category were
174 limited, and market research intelligence reports are still
175 prohibitively expensive [21] . Identified documents were
176 carefully scrutinised and all relevant data extracted by one
177 author (KA) into a project resource file. The extracted
178 data were organised by type (market size and forecast,
179 marketing budgets, marketing strategies and techniques)
180 for reporting findings. Noteworthy data and brand case
181 studies were shared among the article authors for further
182 analysis and use in the qualitative interviews.
183 Qualitative interviews
184 The qualitative interviews were designed to examine: how
185 manufacturers of breast milk substitutes position them-
186 selves and their products to compete against breast milk,
187 using a marketing framework; and how these strategies and
188 approaches are likely to evolve in the future. The aim was
189 to conduct a series of ~ 6–8 semi-structured interviews
190 with industry experts and professionals with experience of
191 marketing BMS and other commercial food products who
192 were willing to talk candidly about their views and experi-
193 ences. These included independent marketing consultants,
194 communications specialists and industry insiders, and those
195 with experience in both high and low income countries.
196 These interviews also involved the collection of case mate-
197 rials and written responses and were supported by add-
198 itional contextual interviews (up to ~ 10) with breast milk
199 and breastfeeding advocates who provided information and
200 advice on accessing industry informants.
201 All interviews were conducted either face-to-face or by
202 telephone, typically lasted 90–120 min and were guided
203 using an interview schedule which was deliberately
204 loosely structured to enable participants to talk flexibly
205 and freely about their experiences. Interviews examined
206 the full breadth of marketing variables (product, price,
207promotion and place, commonly referred to as the 4Ps)
208and how these are used to develop brands and brand
209families. Links to consumer behaviour were examined in
210detail. Participants were also encouraged to discuss how
211BMS are currently being marketed and how this may
212change or develop in the future, especially online and in
213relation to digital marketing. Examples of existing mar-
214keting materials generated from the literature review
215were used as prompts to help stimulate discussion.
216Participants were purposively selected through existing
217professional and academic networks using a combination
218of cascading techniques and personal recommendation,
219and relied on a combination of face-to-face, telephone
220and email communication, along with support from
221breast milk and breastfeeding advocates. Prospective
222candidates were emailed a copy of the study participant
223information sheet and consent form and followed up by
224telephone and/or email as required. Where appropriate,
225commercial participants were offered a fixed cash incen-
226tive as a gesture of thanks for their time and a contribu-
227tion to any costs of taking part. All participants who
228expressed a wish to take part were asked to provide in-
229formed consent, either verbally or in writing. Given the
230sensitive nature of the topic area all participants were of-
231fered full anonymity as part of the conditions for taking
232part. All interviews were conducted by two of the au-
233thors (GH, DE), and for the most part with individual re-
234spondents; in one instance two participants were
235interviewed together. A total of 26 individuals were
236approached for an interview from the UK, Continental
237Europe, North America, Australia and New Zealand,
238with 20 participants agreeing to take part. These in-
239cluded BMS industry representatives with experience in
240formula milk marketing and product development (n =
2416), communications and market research consultants
242with experience in food and social marketing (n = 10),
243public health experts (PHE; n = 2) and breastfeeding ad-
244vocates (n = 2). All of the interviews were completed be-
245tween January and June 2019 and were conducted in
246English with one exception (French); one participant also
247provided a follow-up interview.
248All interviews were recorded on digital voice-file with
249participants’ consent and then professionally transcribed
250and archived using non-identifiable codes prior to
251analysis. Given the small number of interviews in-
252volved, analysis was conducted manually by the two
253authors responsible for conducting the interviews, led
254by GH. The transcripts were reread repeatedly to
255identify emerging themes and the reliability of these
256themes reassessed by a process of cross-examination
257with any interpretative differences resolved through
258discussion. These analyses allowed the investigation
259team to identify patterns across the data as a whole
260and to draw iterative comparisons.
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261 Data synthesis
262 Data from the two research strands were reviewed by all
263 authors for common themes and explanations for how
264 the BMS marketing works and factors which contribute
265 to and help explain its success.
266 Quotes from interviewees and the marketing docu-
267 ments and case studies illustrate the explanations of the
268 marketing techniques used: consumer research, relation-
269 ship building, segmentation and targeting, stakeholder
270 marketing and promotional appeals. The market data,
271 budgets and strategies then contextualise these findings.
272 Results
273 Formula marketing, as for other fast-moving consumer
274 goods, starts with a detailed understanding of the cus-
275 tomer; on this can be built long-term relationships
276 which are strengthened with careful segmentation and
277 targeting. The resulting campaigns work at both a brand
278 and generic level. Maintaining stakeholder support is
279 also important. The fiscal strength of the key players en-
280 sure that this marketing activity is guided by the best
281 global expertise.
282 The quotations in the results section come primarily
283 from the interviewees with direct experience of BMS
284 marketing (formula marketing experts [FMEs]), but the
285 sentiments expressed reflect the comments of all the
286 marketing experts interviewed. In addition, references
287 are made to marketing and business documents, and in
288 these cases citations are included.
289 Understanding your customer
290 Marketing is a complex and sophisticated art. In the for-
291 mula industry, as in other consumer goods sectors, mar-
292 keters seek to solve their customers’ ‘problems’, and to
293 do so effectively it is essential to gain a detailed under-
294 standing of “who are you talking to, what’s in their head,
295 how can you engage them, how do you sell yourself to
296 that person” (FME). The approach is indirect, very much
297 “a soft sell” building faux-friendships rather than making
298 an overt sales pitch: “we want to build a relationship
299 with you as a mother, we want to support you, we want
300 you to see us as an ally and we want to subtly insinuate
301 ourselves as your friend and support in a healthy preg-
302 nancy and a happy baby” (FME). Paradoxically, the only
303 unmistakably factual material that is always included is
304 the ‘breast is best’ declaration required by the WHO
305 Code, but this is also used to good marketing effect.
306 First, it aligns the company with WHO and the public
307 health establishment. Second, it raises the topic of “first
308 milk”, which is supposed to be a no-go area for market-
309 ing: “they cannot legally communicate about the first
310 milk, it’s legally forbidden in most of the countries so they
311 are always playing with the … [requirement to] mention
312 that it is the best thing after the maternal milk” (FME).
313For example, one company’s ‘breast is best’ statement
314continues “unfortunately, not all mothers can breastfeed
315…” , and so into an overt pitch for its products (see
316Fig. F11).
317Third it helps maintain a pretence that formula milk
318does not compete with breast milk: “so they are not even
319competing … they are smarter than that, they are just
320saying yeah, yeah of course the milk from the woman is
321the best, right, however we bring you this, this and this”
322(FME). At the same time, the commercial realities are
323clear: “in the ‘Baby Book’ they do track the percentage of
324what they call ‘share of stomach’, that is breast milk, so
325they are aware of rates of breastfeeding in a country, but
326I never saw any documents or strategies anywhere that
327were about how to get women away from breastfeeding. I
328mean it must be. Surely, it’s in the back of their minds;
329this is the free alternative that is reducing their market
330share, but there wasn’t conscious recognition of that so
331maybe that’s political I don’t know. Maybe the most se-
332nior people, they do talk about it” (FME).
333Building long-term relationships with baby clubs and
334carelines
335The relationship-building, its nuance and subtlety not-
336withstanding, is equally strategic; well-established relation-
337ships will last for years: “[corporation name] is always on
338a quest to find ways to identify women who are pregnant
339for the first time … right when they find out they are preg-
340nant or early in their pregnancy because … how a woman
341feeds her first baby is how she is likely to feed her subse-
342quent babies … first time mothers are the holy grail”
343(FME). Relationships can also span generations: “the music
344of [brand name], Baby Love [by The Supremes], has been
345there for more than forty years … so imagine your mum
346heard it, now you are hearing it; that’s an iconic asset; it’s
347running through generations” (FME).
348Baby ‘clubs’ (Fig. F22) and telephone advice lines are the
349favoured vehicles for establishing and fostering these rela-
350tionships: “we had a particular focus on what they call
351‘one to one marketing’ which is reaching mothers individu-
352ally and building individual relationships with mothers.
353The two big tools in their arsenal, their two favourite tools,
354were the [telephone advice line] and the [baby club] … I’d
355spend a lot of time advising marketing teams [in different
356countries] that the first two things you do are set up your
357[baby club and telephone advice line]; you can then do
358other things, but those are the two direct relationship
359building [tools] with mothers; those are the two ace cards
360to play”. And it is still very much a soft sell: “there is no
361mention of formula on the [telephone advice line], it’s just
362about insinuating the products as your friend”.
363Digital technology has greatly enhanced these tools: “I
364have decks and decks of the different apps and digital
365things that [corporation name] created. Basically, their
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366 process was to ask in a given country what kinds of
367 mothers are we talking to, what are the needs that those
368 mothers have, and therefore what digital marketing do
369 we create to meet those needs” (FME). These apps range
370 from “an online ovulation calculator, to help women get
371 pregnant in the first place” to “an app for mothers to
372 reach other mothers who were up all night, so mothers
373 who have a newborn baby and they are up at three am
374 and they are lonely and bored, could connect to other
375 mothers who are up at the same time and have a chat”
376 (FME). Similarly, “when you sign up to the [baby club]
377 you tell them what your due date is and whether you are
378 at two months or eight months or wherever you are, and
379 then you step into a series of emails that are timed to
380 your stage of pregnancy” (FME). In return for this
381targeted support, the company gets a constant stream of
382personal data as well as enhanced sales: “they had signifi-
383cant evidence to show that these are effective at driving
384sales literally … they had very good evidence to show that
385if a woman is in the [baby club], if a woman has called
386the [telephone advice line], there is a significant correl-
387ation with her ultimately buying [corporation name’s]
388products” (FME).
389Segmentation and targeting
390This type of bespoke marketing means that one size will
391not fit all. The personal data are therefore used to seg-
392ment customers into smaller, more homogenous target
393groups which then receive suitably honed approaches:
394“so, globally, [corporation name] target basically three
f1:1 Fig. 1 Breast is best, but
f1:2
f2:1 Fig. 2 Baby Clubs
f2:2
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395 kinds of mothers, and this is true in every country, so they
396 call them Blue, Yellow and Red mothers (Fig.F3 3) … speak-
397 ing of segmentation there’s your big three global categor-
398 ies” [FME]. In western countries, for example, the
399 market principally comprises Blue and Yellow mothers,
400 and there is a clear difference in the type of advertising
401 they receive. Blue mothers (and fathers) get reassuring
402 technical claims and promises about their child’s future
403 from “our most advanced formulation yet” (Fig. 3): “‘in-
404 spired by forty years of breast milk research’, that’s a very
405 clever claim, which essentially doesn’t mean anything
406 technically, but which is a very clever way to imply to re-
407 duce guilt about not breastfeeding” … “That is a bang on
408 for Blue mothers, ‘their future starts today’, she (mum)
409 absolutely believes that” (FME) Meanwhile, for Yellow
410 mothers the pitch is to “nourish their happiness” (FME)
411 backed up by lots of gurgling, happy babies doing
412 endearing things. The call-outs for the baby clubs (Fig.
413 2) epitomise these distinctions.
414 Again, this is strategic: target groups do not just get
415 their own advertisements, they get their own brands,
416 each backed by multifaceted marketing effort. New
417 product development, such as ‘follow-on’ milks, ‘special-
418 ist’ formulas, or, the “BabyNes for It Moms baby nutri-
419 tion system” (an espresso-like machine which uses pods
420 to deliver “the exact perfect dose of milk for your baby”)
421 [23], keeps the category vibrant, and in the case of spe-
422 cialist formulas, builds useful links with the medical es-
423 tablishment (see below). Point of sale display in both
424 pharmacies (for associations of quality and medical re-
425 spectability) and supermarkets (for associations of value)
426ensures ready access. Pack design reinforces brand values
427and links first milks with other products. (See for example,
428p.35 of Harris et al. for images [24].) All of this brand sup-
429port is vital because “it’s brands that give things meaning,
430… it’s a short cut for communication, it bestows white pow-
431der with meaning that attracts a certain kind of woman
432and gets her to buy it” (FME). They give product and com-
433pany a human face, a personality, a story to tell; and the
434sales pitch remains subtle, it is possible to “create a brand
435affinity without mentioning product” (FME).
436This makes regulation extremely difficult: “When [corpor-
437ation name] market infant formula they do need to tiptoe a
438bit around stuff before 12 months [promoting formula for
439babies under 12 months is supposed to be prohibited], but
440they still do all sorts of things. They don’t talk about product
441at all, it’s like, ‘Call our [telephone advice line]’, ‘Join our
442[baby club]’, no mention of a product, so you can still mar-
443ket without talking about a product” (FME).
444Generic effects
445Formula promotion also has a generic effect, as an
446award-winning campaign from a US multinational dem-
447onstrates (Fig. F44). A dramatic rise in US breastfeeding
448rates was identified as a threat, and this was being exac-
449erbated by negative media coverage about BMS. As a re-
450sult, the brand was being undermined. An advertising
451agency was therefore commissioned to “reinvigorate the
452Similac brand” and also “change the face of an entire in-
453dustry” [25]. The result was the “Sisterhood of Mother-
454hood” campaign using the formula trope of “doing what’s
455best for baby” [25]. At its core is a video showing a
f3:1 Fig. 3 Global Market Segmentation: Blue, Yellow and Red Mothers
f3:2
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456 group of parents arguing in a public park, criticising
457 each other for their choices and differences (about nap-
458 pies/careers/sexuality/gender/feeding) but when one of
459 the buggies (strollers) runs away down the hill they stop
460 fighting and become united in their instinct to save the
461 baby, which, with palpable relief, they succeed in doing
462 [26]. The strapline then appears: “no matter what our
463 beliefs, we are parents first – welcome to the Sisterhood
464 of Motherhood”. It “was the most successful campaign
465 ever for Similac” resulting in increased sales and vastly
466 improved media coverage [25]. It also succeeded in
467 changing the narrative about infant feeding, which is no
468 longer a matter of scientific evidence, but lifestyle
469 choices and beliefs. Breastfeeders are positioned as just
470 one minority, with one set of beliefs.
471 Cognitive dissonance
472 This conceit that breast and bottle equate may help ease
473 dissonance among formula marketers: “everyone ‘drinks
474 the Kool-Aid’ that it’s a good thing, it’s based on breast
475 milk research, it’s fairly genuine from the inside. No, I
476 don’t think anyone thinks about it as reducing rates of
477 global breastfeeding, most people come from commercial
478 marketing backgrounds in which you sell software, you
479 sell sausages, oh we are selling baby food, fine …” (FME).
480 But, it does not entirely remove the disquiet: “So, did I
481 have qualms at the time? No. Would I go back to it? No,
482 I wouldn’t” (FME). The change of heart comes from
483external stimuli (in this case participating in the study
484played a role), not the industry: “Nowhere is there men-
485tion of that within [corporation name] there is no sense
486that you know we are basically selling tobacco, there is
487no, there is no consciousness of that that I detected … I
488don’t think we would have worked in it if we thought we
489were doing something evil” (FME).
490Targeting the medical establishment
491The industry takes care to keep external stimuli support-
492ive by building strong financial and educational links with
493the medical establishment: “It creates a normality when
494the Royal Colleges [two names] that lay out the infant
495feeding guidelines, and set policy [in the UK], and set the
496standard, and create leadership culture … both now have
497relationships with [two corporation names]. It sanitises it,
498in my view, it’s a brand sanitiser, where we have key opin-
499ion leaders, Royal Colleges, our leading paediatric institu-
500tions in terms of hospitals [two names] all having
501comfortable and cosy relationships with infant formula”
502(PHE). The principal vehicle for this stakeholder market-
503ing is ‘specialist formula’: “The Royal College is very clear
504that it only accepts money for specialist formula, it doesn’t
505accept money for general formula. Now the [WHO] Code
506is also very clear about the marketing of breast milk substi-
507tutes, and that these specialist formulas are definitely
508breast milk substitutes, and they normalise interactions
509between industry and the profession” (PHE). The medical
f4:1 Fig. 4 The sisterhood of motherhood [60]
f4:2
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510 profession can also provide a means of circumventing
511 regulation, as another prize-winning campaign explains:
512 “Mead Johnson communicated the benefits of its Enfa A+
513 Gentlease baby formula directly to doctors, to work around
514 advertising regulations in the Philippines … The approach
515 resulted in 40% sales growth after three months” [27].
516 More fundamentally, there was unease about commerce
517 intervening in such a profoundly human area: “the first key
518 moment [of pregnancy]”, “the departure point”, is “really
519 not addressed by anybody except the brands” (FME). The
520 search for competitive advantage can also be disturbing:
521 “one I find awful, in Indonesia, that they are already
522 enriching the milk to help develop the brain even more be-
523 cause [customers] really feel that from childhood [their
524 child] needs to have more, more, more; this I found very
525 tricky … it is going too far you know?”; “In [corporation
526 name], the next big innovation was epigenetics, so the
527 whole idea that a baby’s success starts very early and that
528 genes change generation to generation, so if there are
529 stresses in the environment, that’s encoded in genes. But
530 basically it’s saying you need to be concerned about your
531 baby, not just from birth but from way before birth. And I
532 think the next thing they were going to promote with
533 [brand name] is that it appeals to epigenetics in some way
534 as well, which is very Blue mother. That’s what they were
535 planning; … that was the next big thing coming down the
536 pipeline” (FME). A 2016–17 multimedia campaign for a
537 follow-on milk in Indonesia, is explained as addressing the
538 “sceptical consumer” by launching “the [brand name]
539 Grow Them Great Campaign to talk about [brand name]‘s
540 functionality story”; that the formula delivers “benefits such
541 as [a] developed brain, good digestive system and well-
542 rounded child” [28].
543 Fiscal power
544 Market size and forecast
545 Processed food production in the global market is domi-
546 nated by a handful of powerful multinational corporations.
547 Nestlé (US$19,370m brand value) and Danone (US$9098
548 m brand value) were ranked globally by Brand Finance as
549 the two most valuable food brands in 2018 and ranked by
550 Kantar Worldwide in 2017 as 13th and 19th, respectively,
551 for household reach among the leading fast-moving con-
552 sumer goods brands worldwide [29]. The global dairy in-
553 dustry generated sales of US$204.4bn in 2017, based on
554 Rabobank data from the 20 leading dairy corporations
555 [29]. BMS products are just one category within a huge
556 portfolio of products these global corporations produce.
557 Data from 2015 demonstrated that six multinational
558 corporations controlled more than half of the global baby
559 food market (including BMS), Nestlé followed by Danone
560 holding the biggest shares, and Kraft Heinz, Mead
561 Johnson, Abbott and FriesslandCampina the remaining
562 four (Euromonitor International, 2015, as cited by Save
563the Children [18]). In 2015, Euromonitor International
564valued global BMS retail sales at US$47bn globally and
565Nestlé as the lead company accounted for 22% of these
566global sales [30]. Forecasting by Euromonitor for the
567WHO, based on the upward sales trajectory and market
568research to 2014, predicted that global sales would be
569worth US$70.7bn by 2019 [11]. Another, more conserva-
570tive, estimate for investors by a multinational vegetable
571fats producer using 2016 Euromonitor data suggest the
572global retail value will be US$62.5bn by 2020, and breaks
573the forecast down by category: 29% standard formula (0–
5746months), 21% follow-on formula (6–12months), 43%
575toddler formula (> 12months) and 7% special formula
576(e.g. premature and allergy) [31].
577Marketing budgets
578The marketing budget data we identified are from dis-
579parate sources and we concur with Piwoz and Huffman
580on the difficulty of finding open access comprehensive
581or verifiable data on how much money companies spend
582to market BMS products [14]. Overall annual advertising
583expenditure in 2018–19 for the two companies holding
584the largest portions of the global baby food and drinks
585market was US$944.5 m for Nestlé USA, Inc. (Glendale,
586CA) for national advertising expenditure that included
587above-the-line advertising channels plus sponsorship
588[32], and US$1143.3 m for Groupe Danone S.A. (Paris)
589for traditional media advertising, direct mail, point of
590purchase and product samples [33]. Another business
591data source described the US Mead Johnson Nutrition
592Company as one that markets its BMS and children’s
593nutrition product lines to both parents and health care
594professionals in Asia, Europe, Latin America and North
595America. The company spent $223.8 million on advertis-
596ing on “TV, print, and other consumer media, with an
597increasing focus on social and other direct media in
5982016, up from $206.2 million in 2014” [34].
599Older Nielsen data, from 2015, breaks down advertising
600spend by Nestlé SA in the USA, as US$5.58m on advertis-
601ing infant formula and US$4.01m on toddler milk [24].
602Abbott spent US$3.36 advertising infant formula and
603US$20.71m advertising nutritional supplement in the
604USA in 2015, and Mead Johnston Nutrition spent
605US$12.82m advertising toddler milk and US$0.81m on
606infant formula [24]. Overall, US$9.75m was spent on ad-
607vertising infant formula and US$16.83 on advertising tod-
608dler milk in the USA in 2015, mostly on television and in
609magazines [24].
610In the UK, Nielsen data show that £13.2m (approx.
611US$16.1m) was spent on advertising BMS in 2018 using
612traditional media channels (which excludes sponsorship,
613search and social advertising channels), up 12% from the
614previous year but 23% lower than in 2015 [35]. BMS adver-
615tising comprised 80% of the total advertising expenditure
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616 for baby food and drinks [35]. Further analysis of Nielsen
617 advertising data by Mintel, showed that Danone (the UK
618 market-leader in sales value and volume) spent £13.4m on
619 baby food and drink (including BMS), and spent more ad-
620 vertising its follow-on milks (83% of spend) than other in-
621 fant formula brands. As the analysts note later in their
622 report, “The key to growth will be in keeping older toddlers/
623 pre-schoolers buying into the category [baby food and drink]
624 for longer, if the birth rate continues to decline”. Advertising
625 spend by Nestlé in the UK in 2018 was far lower (less than
626 £0.1m), a “dramatically reduced” spend from the historic-
627 ally major spender [35].
628 Profit margins and pricing strategies
629 An analysis of company reports from five of the biggest
630 baby food companies gave an indication of the profitabil-
631 ity of the broader baby nutrition category. A 23.3%
632 weighted average of profits demonstrates why investors
633 are interested in the category [18, 36]. Some business
634 analyst reports described BMS products as “high-margin”
635 categories, alongside pet food and premium coffee (e.g.
636 by Business Monitor International [37]).
637 Companies have taken the opportunity to premiumise
638 their BMS products. In an investor seminar presentation,
639 Danone endorsed their brands and strategies for mid- to
640 long-term growth drivers in the Chinese market, includ-
641 ing Aptamil Classic, Nutrition Classic and Aptamil Plat-
642 inum, as being “well suited to address untapped
643 opportunity in ultra-premium IMF [infant milk formula]
644 segments”, divided into pricing segments described as
645 “mainstream … super premium … ultra-premium …
646 [and] ultra-premium+” [38]. Similarly, in 2017 Mead
647 Johnson describe their ‘routine’ infant formula products
648 and their ‘premium-priced’ product, the latter intro-
649 duced into “certain geographies” (for the United States
650 ‘Enspire’, and in China ‘Enfinitas’) with innovative com-
651 ponents alleged to be “naturally found in human breast
652 milk [to] provide important benefits (lactoferrin to sup-
653 port immune health and MFGM [Milk Fat Globule
654 Membrane] to foster cognitive development)” [39].
655 Global reach
656 Other global stakeholder companies include, for example,
657 the suppliers of supplementary ingredients and packaging
658 to the BMS industry. One US firm has agreements to sup-
659 ply docosahexaenoic acid to almost 30 BMS manufac-
660 turers that market products in more than 75 countries
661 [40]. A packaging firm in Sweden, with 15 production sites
662 in ten countries, counts the BMS industry as key cus-
663 tomers of their “high-performance barrier packaging solu-
664 tions … to protect and promote the content” [41].
665 The size and global reach are viewed by business ana-
666 lysts as an asset. The acquisition of Mead Johnson Nutri-
667 tion Company by Reckitt Benckiser Group Plc in June
6682017 “supports future growth operations and expansion
669plans in various developing markets such as China,
670Vietnam and the Philippines and in various other parts
671of Latin America region” [42]. Through Mead Johnson’s
672Enfamil brand (infant formula, children’s nutrition, and
673other nutritional products) and Nutramigen brand (spe-
674cialty formula products) the company markets and sells
675approximately 70 different products to mothers, health
676care professionals, and retailers in 50 countries in Asia,
677North America, Latin America, and Europe [42].
678Analyses funded by the WHO have estimated the car-
679bon footprint, as greenhouse gas emissions, from the
680production, emissions from transport and in-home ster-
681ilisation of bottles, and preparation of powdered BMS
682targeted at infants of 0–6 months to be consistently
683higher than that for breastfeeding in all the countries
684tested [43]. Breastfeeding’s carbon footprint included
685carbon cost of the additional food required to maintain
686the mother’s energy balance while breastfeeding. The
687WHO have also cited USA data for the vast tonnage of
688single-use BMS packaging (plastics, cans, metal and
689paper) that ends up in landfills [11]. Some of the most
690popular BMS products in the USA are ready-to-feed
691single-use plastic bottles of formula with teats.
692Lobbying power
693Marketing to policy makers by “treating government de-
694partments as discrete markets to be targeted and sold to,
695as well as understanding the culture and buying process,
696… [using] public affairs departments … to influence gov-
697ernment and to create good relations with them” is part
698of a corporate strategy [44]. There is an imbalance of
699government fiscal policies in many countries that have
700incentivised families to use BMS rather than to breastfeed
701[45]. These have included government-subsidised BMS
702products provided through community welfare programs
703and BMS companies providing health workers’ education
704and training within countries’ hospital and public health
705frameworks. Further, partnerships between the BMS
706industry and government are increasingly proposed as so-
707lutions to infant and child food security issues [46]. Evi-
708dence of commercial stakeholders in the BMS industry
709influencing local policies for infant feed practices has been
710reported in several countries [14], and more recently in
711the USA, lobbying by industry stakeholders intensified be-
712fore a meeting of the WHA in 2018 [47].
713Discussion
714This small-scale study, in which we analyse how formula
715marketing and its key components work, is based on in-
716terviews with practitioners, some of whom have worked
717within the industry, and a review of secondary sources
718which detail business methods. Previous studies have de-
719scribed formula marketing and tried to unpick its impact
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720 on behaviour; to our knowledge ours is the first investi-
721 gation to look underneath the hood and examine how
722 the engine works. We have also assessed the size and
723 power of the Formula Industry, to provide an indication
724 of the resources it has at its command. The results make
725 uncomfortable reading.
726 New parents are often extremely vulnerable; raising a
727 baby is immensely challenging, and almost all parents
728 are primarily motivated by doing the ‘best’ for their child
729 in whatever circumstances they find themselves. They
730 badly need reassurance and support. They also need a
731 convenient and dependable way of feeding their child: a
732 healthy diet compatible with hectic modern life, and the
733 norm of working mothers and fathers. Formula compan-
734 ies have developed an intimate understanding of these
735 needs and are delivering to them with a combination of
736 ‘sympathetic’ relationship building, non-judgemental
737 support, individually targeted communications, a readily
738 available range of reliable products and the construction
739 of reassuringly familiar and evocative brands. Digital
740 marketing, where the social and commercial have
741 melded, is greatly enhancing their efforts, whilst making
742 the breadth of industry marketing strategies increasingly
743 difficult to track and document.
744 The reach and wealth of the multinational corporation
745 has turned this soft power into a very hard global force.
746 The BMS market is worth about US$70bn per annum and
747 is controlled by six of the most powerful food companies
748 in the world, with massive household and global reach.
749 High profit margins offer attractive investment and busi-
750 ness opportunities. Marketing spend is extremely difficult
751 to quantify accurately but certainly runs into billions of
752 dollars annually, which is used to target governments and
753 stakeholders as well as consumers. This is corporate mar-
754 keting at its most powerful and disturbing.
755 The concerns are twofold. First, in most cases, formula
756 feeding is not the best option, from a health or ecological
757 standpoint. As noted above, its use is causing immense
758 harm to babies, mothers and the environment. Second,
759 the marketing is built on deception. Infant formula is in
760 reality the definitive one-size-fits-all product. By law all
761 products must have the same formulation, as established
762 by independent research. The only permitted variation
763 from this is for unproven additives, which if they ever
764 prove to be beneficial, would, again by law, have to be
765 added to all formula products. The product ranges, the
766 segmentation and bespoke targeting, the carefully honed
767 brands are simply subterfuge. In the UK the two leading
768 and supposedly very different brands which dominate the
769 market are in fact made by the same multinational.
770 This study was limited to a small number of interviews
771 and relied on access to secondary data, mostly from
772 high-income economy countries. Thus it is not represen-
773 tative and in particular reveals less than we would like
774about what is happening in the global south. Nonethe-
775less, it provides key insights into how infant formula
776marketing works, and adds to our understanding of how
777international business impacts ill-health [48].
778Conclusions
779There is an urgent need to shed more light on the harm
780being done by infant formula marketing; its extent is
781revelatory to all but a small group of public health ex-
782perts. Even the marketing practitioners who had worked
783in the industry were taken aback by it and began to ex-
784press overt regrets about their past actions. Just as for-
785mula is being normalised, so too is formula marketing.
786Corporate marketing careers move between companies
787and sectors – from formula to supermarkets to tech –
788this unthinking and completely unwarranted moral
789equivalence has to be challenged. The medical establish-
790ment has also been pulled into this charade; just as fifty
791years ago it had to rethink tobacco, so today it needs to
792review fundamentally its relationship with the formula
793industry. The recent decision by the BMJ and sister jour-
794nals to refuse infant formula advertising is a welcome
795move in this direction [49].
796The regulation of marketing needs to be greatly
797strengthened; as one marketing practitioner observed:
798“the most effective response would be to prohibit any for-
799mula marketing at all; much like is done with tobacco”
800(FME). The point is well-made, but formula is not to-
801bacco; it can be an essential option in specific circum-
802stances – with preterm or SGA (small-for-gestational-
803age) infants, for instance, or when, even with optimal
804support, breastfeeding proves impossible. The problem
805is not the product but rather out-of-control marketing,
806which is driving dangerous over-consumption in the in-
807terests of corporate profits. This needs to change. The
808sole purpose of communications about formula should
809be to help parents and carers make the best possible de-
810cision for the baby. Advertising does nothing to help in
811this regard. It promotes spurious product differences
812and reinforces these with confected brands. In its digital
813form, which has become so prominent in recent years, it
814is particularly manipulative. All this advertising should
815cease forthwith, as demanded by the WHO Code four
816decades ago [16]. The pack should be unbranded and
817become a platform for objective guidance, from an
818accredited public health source, explaining the product
819contents, how it should be used and by whom. Point of
820sale activity should add further health promotion sup-
821port, again from an independent source. Pricing also
822needs be tightly regulated; infant formula is immensely
823profitable for a small number of multinational corpora-
824tions, while the costs to society are enormous. In
825addition, it should no longer be possible to use price as
826a bogus indicator of quality.
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827 Only with these radical revisions will we get a n infant
828 formula market that serves the needs of babies and their
829 parents rather than shareholders. They are big steps that
830 will take careful, sustained management and will meet
831 resistance from very powerful vested interest. In other
832 contested fields, where radical change is needed, such as
833 tobacco and climate, a Framework Convention, with its
834 global reach, has provided the answer [50]; the equiva-
835 lent is now needed for infant feeding.
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